This systematic review aims to determine the effectiveness of corticosteroids in treating anosmia in COVID 19 patients. This study used a systematic review approach in gathering data, from scouring through web-based journals into sifting through unrelated studies. The sifting process are levelled with varying degrees of specificity, from the PICO (Population, Intervention, Comparison, Outcome) which were Post COVID-19 patients with anosmia, corticosteroid therapy, placebo treatment, and an outcome in clinical recovery. The papers that fit the PICO criteria then were sifter through inclusion and exclusion criterias such as : it has to be a Randomised Clinical Trial (RCT), there are uses of corticosteroid, and the subjects were post covid patients. There were first searched with keywords of anosmia, COVID-19, corticosteroid through Pubmed (n=5) Google Scholar (n=200), SCOPUS (n=175), EBSCO (n=121), ScienceDirect (n=186). After gathering those papers, it was then judged based on their abstract for inclusion criterias and exclusion criterias. The final studies that were in this systematic review consists of three studies. The end results showed that there were no effectivity of corticosteroids in treating anosmia in post covid patients.

Introduction: One of the causes of acute kidney injury that is increasingly soaring is preeclampsia syndrome. Globally, the maternal mortality rate reaches 287,000 per year, and preeclampsia is a major contributor. From East Java Provincial Health Office data, per 100,000 pregnancies, 114 had preeclampsia syndrome. Anemia is one of the highest causes of maternal death, the global prevalence of anemia in pregnant women reaches 55.9%. There have not been many significant studies on the effect of anemia with the incidence of preeclampsia.Methods: This was observational analytic study with a case and control design which used a chi-square and fisher exact measurement tool. The data samples were patients of pregnant women who had preeclampsia syndrome categorized as cases, and those who did not have preeclampsia were categorized as controls. The data has been obtained from medical records; these include ages, the number of parities, the number of pregnancies, body mass index (BMI), the number of childbirths, types of preeclampsia, and hemoglobin levels. The data has been obtained from the result of the medical record observations that were processed and analyzed in descriptive of statistics which used percentage and cross tab.Results: The case study group or preeclampsia pregnant women who experienced anemia were 34 patients or 50% of 68 pregnant women and in the control group were 53 patients or 39% of anemia patients out of 136 patients. The chi-square statistical test obtained values (p = 0.133). The samples needed were 68 case groups and 136  cases as controls.Conclusion: There was no relationship between anemia and preeclampsia.